Company intelligence
CCIT-DK - National Center for Cancer Immune Therapy of Denmark
CCIT-DK, National Center for Cancer Immune Therapy of Denmark
About CCIT-DK - National Center for Cancer Immune Therapy of Denmark
The Danish National Center for Cancer Immune Therapy (CCIT-DK) bridges the gap between discovery and clinical implementation in the field of cancer immunotherapy at Copenhagen University Hospital, Herlev and Gentofte, Department of Oncology. Strong collaboration with the Danish Cancer Society #dkforsk #dksund SoMe manager @Lise Riber Lucassen and @Marco Donia
Verified activity
Signals from CCIT-DK - National Center for Cancer Immune Therapy of Denmark
3 published signals
Research & Knowledge
CCIT-DK - National Center for Cancer Immune Therapy of Denmark published a study in Signal Transduction and Targeted Therapy identifying a melanoma-enriched noncanonical antigen and a T-cell receptor capable of recognizing this target.
Reported by CCIT-DK - National Center for Cancer Immune Therapy of Denmark
Research & Knowledge
CCIT-DK - National Center for Cancer Immune Therapy of Denmark is preparing a new clinical research trial for patients with follicular lymphoma managed with watch-and-wait, aiming to start next year.
Reported by CCIT-DK - National Center for Cancer Immune Therapy of Denmark
Presence & Recognition
CCIT-DK - National Center for Cancer Immune Therapy of Denmark featured its ESMO podcast on “Vaccine Therapies: The Way Forward” on the ESMO homepage.
Reported by Mads Hald Andersen